Impact of tumour size measurement inter-operator variability on model-based drug effect evaluation

PURPOSE: During oncology clinical trials, tumour size (TS) measurements are commonly used to monitor disease progression and to assess drug efficacy. We explored inter-operator variability within a subset of a phase III clinical trial conducted from August 1995 to February 1997 and its impact on dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombard, Aurélie, Mistry, Hitesh, Chapman, Sonya C., Gueoguieva, Ivelina, Aarons, Leon, Ogungbenro, Kayode
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125250/
https://www.ncbi.nlm.nih.gov/pubmed/32170415
http://dx.doi.org/10.1007/s00280-020-04049-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125250/
https://www.ncbi.nlm.nih.gov/pubmed/32170415
http://dx.doi.org/10.1007/s00280-020-04049-5

Ejemplares similares